Cargando…
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
The marketing authorization granted to SARS-Cov-2 vaccines was accompanied by reinforced safety monitoring plans. These plans’ implementation was part of the usual logic of post-marketing surveillance of new and innovative health products. It was especially adapted to the context of post-marketing m...
Autores principales: | Pariente, Antoine, Bezin, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103672/ https://www.ncbi.nlm.nih.gov/pubmed/34119319 http://dx.doi.org/10.1016/j.therap.2021.05.002 |
Ejemplares similares
-
Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017) -
Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016) -
Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
por: Alping, Peter, et al.
Publicado: (2019) -
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
por: Mathieu, Clément, et al.
Publicado: (2022) -
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)